Scientists identify strong genetic markers for PTSD

NewsGuard 100/100 Score

Post-traumatic stress disorder (PTSD) is the most commonly occurring and seriously debilitating disorder that happens when a person gets exposed to traumatic events, including sexual assault, combat, and natural disaster.

Image Credit: Feng Yu / Shutterstock
Image Credit: Feng Yu / Shutterstock

The World Health Organization (WHO) reports that about 3.6 percent of the world’s population had experienced PTSD in a given year. In the United States, the condition affects 3.5 percent adults, and approximately one in 11 people will be diagnosed with PTSD in their lifetime, which is about 8 million adults.

PTSD may develop in people who experience a traumatic event, but the exact reason why only a fraction of people develops the condition is still unclear. Some studies have shown that the condition is only a social effect, but other studies pointed out that genetics may play a role in the emergence of the illness.

Now, a team of researchers at UC San Diego Health determined the link between genetics and PTSD. In a multi-ethnic cohort including more than 30,000 PTSD cases and 170,000 controls, the researchers conducted a genome-wide study to determine if the risk of developing PTSD is heritable.

The study, which was published in the journal Nature Communications, the team of researchers demonstrated significant genetic correlations in 60 PTSD cohorts. This is the largest and most diverse genetic study of PTSD, showing that PTSD has a strong genetic component just like other mental health disorders.

The research aims to formulate new tools that can provide knowledge and the ability to clinicians to predict patients with the greatest risk of developing PTSD. This way, they can tailor their treatments to the patient’s needs. There is no guarantee that people are protected from trauma, but there should be timely and appropriate treatments available.

PTSD is polygenic

Just like other psychiatric disorders, PTSD is polygenic, which means that it is linked with thousands of genetic traits. All these genetic traits contribute to the condition. A total of three genome-wide significant risk loci were determined, one in African ancestry and two in European ancestry analyses.

The researchers also identified and studied the data based on sex, and another three risk loci have been identified in men, again, one in African ancestry and two in European ancestry. Surprisingly, the gene involved in Parkinson’s disease, PARK2, which is vital for the regulation of dopamine, is also tied to PTSD.

"Based on these findings, we can say with certainty that there is just as much of a genetic component to PTSD risk as major depression and other mental illnesses," Karestan Koenen, a professor of psychiatric epidemiology in the Harvard T.H. Chan School of Public Health, said.

“Our limited ability to study the living human brain and uncover the biological roots of PTSD has contributed to the lack of treatments and the stigma around this debilitating condition. Genetics helps us make discoveries, find opportunities for new therapies, and counter that stigma,” she added.

The researchers emphasize the importance of having a better understanding of genetic risks, biological mechanisms, and the disease process linked with PTSD. This way, scientists can come up with medical breakthroughs for better prevention and treatment of mental illness.

PTSD can take a toll on the lives of many people affected, which can lead to other arrays of health and psychiatric issues. The researchers encourage that further research should be conducted to determine other ways to treat and manage PTSD, hence, helping millions who suffer from the condition.

More about PTSD

Post-traumatic stress disorder (PTSD) is a disorder that usually develops when a person experiences a traumatic, shocking, dangerous, or scary event. The common signs and symptoms of the disorder include flashbacks of the traumatic event, bad dreams, and frightening thoughts. Other symptoms include staying away from places, people, or events that remind of the experience, having a tense feeling, being easily startled, trouble remembering key features of the event, distorted feelings, and loss of interest in enjoyable activities.

Journal reference:

Nievergelt, C. Maihofer, A., and Koenen, K. (2019). International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nature Communications. https://www.nature.com/articles/s41467-019-12576-w

Angela Betsaida B. Laguipo

Written by

Angela Betsaida B. Laguipo

Angela is a nurse by profession and a writer by heart. She graduated with honors (Cum Laude) for her Bachelor of Nursing degree at the University of Baguio, Philippines. She is currently completing her Master's Degree where she specialized in Maternal and Child Nursing and worked as a clinical instructor and educator in the School of Nursing at the University of Baguio.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Laguipo, Angela. (2019, October 09). Scientists identify strong genetic markers for PTSD. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20191009/Scientists-identify-strong-genetic-markers-for-PTSD.aspx.

  • MLA

    Laguipo, Angela. "Scientists identify strong genetic markers for PTSD". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20191009/Scientists-identify-strong-genetic-markers-for-PTSD.aspx>.

  • Chicago

    Laguipo, Angela. "Scientists identify strong genetic markers for PTSD". News-Medical. https://www.news-medical.net/news/20191009/Scientists-identify-strong-genetic-markers-for-PTSD.aspx. (accessed April 26, 2024).

  • Harvard

    Laguipo, Angela. 2019. Scientists identify strong genetic markers for PTSD. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20191009/Scientists-identify-strong-genetic-markers-for-PTSD.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Merck introduces Aptegra CHO genetic stability assay for accelerated biosafety testing